Novogene Co., Ltd. (688315.SS)
CNY 14.06
(0.21%)
CNY 14.06
(0.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 855.55 Million CNY | 0.36% |
| 2022 | 852.67 Million CNY | 6.52% |
| 2021 | 800.46 Million CNY | 52.95% |
| 2020 | 523.34 Million CNY | -12.91% |
| 2019 | 600.93 Million CNY | 33.0% |
| 2018 | 451.82 Million CNY | 42.76% |
| 2017 | 316.48 Million CNY | 43.82% |
| 2016 | 220.06 Million CNY | 35.59% |
| 2015 | 162.29 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 188.83 Million CNY | -21.89% |
| 2024 Q2 | 219.39 Million CNY | 16.18% |
| 2024 Q3 | 231.37 Million CNY | 5.46% |
| 2023 Q2 | 206.19 Million CNY | 14.31% |
| 2023 Q3 | 227.38 Million CNY | 10.28% |
| 2023 Q4 | 241.76 Million CNY | 6.32% |
| 2023 Q1 | 180.37 Million CNY | -28.9% |
| 2023 FY | 855.71 Million CNY | 0.36% |
| 2022 Q1 | 163.05 Million CNY | -40.86% |
| 2022 Q4 | 253.68 Million CNY | 5.59% |
| 2022 Q3 | 240.24 Million CNY | 22.77% |
| 2022 Q2 | 195.68 Million CNY | 20.01% |
| 2022 FY | 852.67 Million CNY | 6.52% |
| 2021 Q3 | 209.14 Million CNY | 23.82% |
| 2021 FY | 800.46 Million CNY | 52.95% |
| 2021 Q4 | 275.7 Million CNY | 31.83% |
| 2021 Q2 | 168.9 Million CNY | 15.12% |
| 2021 Q1 | 146.71 Million CNY | -34.7% |
| 2020 Q3 | 798.13 Million CNY | 714.37% |
| 2020 Q2 | 98 Million CNY | 77.14% |
| 2020 FY | 523.34 Million CNY | -12.91% |
| 2020 Q1 | 55.32 Million CNY | -81.61% |
| 2020 Q4 | 224.67 Million CNY | -71.85% |
| 2019 Q4 | 300.84 Million CNY | -58.86% |
| 2019 Q3 | 731.2 Million CNY | 40193.35% |
| 2019 Q2 | 1.81 Million CNY | -94.65% |
| 2019 FY | 600.93 Million CNY | 33.0% |
| 2019 Q1 | 33.94 Million CNY | -76.8% |
| 2018 Q1 | 79.6 Million CNY | 0.0% |
| 2018 Q4 | 146.31 Million CNY | 0.0% |
| 2018 FY | 451.82 Million CNY | 42.76% |
| 2018 Q3 | 146.31 Million CNY | 83.81% |
| 2018 Q2 | 79.6 Million CNY | 0.0% |
| 2017 FY | 316.48 Million CNY | 43.82% |
| 2016 FY | 220.06 Million CNY | 35.59% |
| 2015 FY | 162.29 Million CNY | 0.0% |